FDA Inspection 1224855 — Philips North America

Philips North America — FEI 3006648320

The FDA completed an inspection of Philips North America on December 13, 2023 in Cambridge, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). 3 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
December 13, 2023
Fiscal Year
2024
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Cambridge, MA (United States)

Citations

IDCFRDescription
1471321 CFR 820.198(a)Lack of or inadequate complaint procedures
313021 CFR 820.100(a)Lack of or inadequate procedures
328221 CFR 820.90(a)Nonconforming product, Lack of or inadequate procedures